ES2165514T3 - Compuestos heterociclicos para el tratamiento de la isquemia miocardiaca. - Google Patents
Compuestos heterociclicos para el tratamiento de la isquemia miocardiaca.Info
- Publication number
- ES2165514T3 ES2165514T3 ES96927083T ES96927083T ES2165514T3 ES 2165514 T3 ES2165514 T3 ES 2165514T3 ES 96927083 T ES96927083 T ES 96927083T ES 96927083 T ES96927083 T ES 96927083T ES 2165514 T3 ES2165514 T3 ES 2165514T3
- Authority
- ES
- Spain
- Prior art keywords
- pct
- compounds
- optionally branched
- miocardiac
- ischemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 208000028867 ischemia Diseases 0.000 title 1
- -1 nitro, hydroxy Chemical group 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
LA INVENCION SE REFIERE A NUEVAS N OXIALCOIL LA CUAL R SUB,1} A R SUB,4}, IGUALES O DIFERENTES, REPRESENTAN: UN HIDROGENO, UN ALCOILO RAMIFICADO O NO QUE CONTIENE DE 1 A 4 ATOMOS DE CARBONO; UN ALCOILOXI RAMIFICADO O NO QUE CONTIENE DE 1 A 4 ATOMOS DE CARBONO; UN GRUPO HALOGENO; UN GRUPO NITRO; UN GRUPO HIDROXI; UN GRUPO TRIFLUOROMETILO O TRIFLUOROMETOXILO. R SUB,5} REPRESENTA: UN HIDROGENO, UN ALCOILO RAMIFICADO O NO QUE CONTIENE DE 1 A 6 ATOMOS DE CARBONO; UN FENILALCOILO RAMIFICADO O NO QUE CONTIENE DE 7 A 12 CARBONOS Y QUE PUEDE ESTAR SUSTITUIDO EN EL ANILLO AROMATICO POR UNO O DOS RADICALES DEFINIDOS COMO R SUB,1}. W Y X REPRESENTAN UN OXIGENO O UN AZUFRE. Y REPRESENTA UN GRUPO POLIMETILENICO QUE CONTIENE ENTRE 2 Y 6 ATOMOS DE CARBONO; EL RADICAL ; N PUEDE ADOPTAR LOS VALORES 0 O 1. LA INVENCION SE REFIERE TAMBIEN, CUANDO LOS HAY, A LOS ISOMEROS R O S PUROS Y SUS MEZCLAS. LA PRESENTE INVENCION INCLUYE LAS SALES MINERALES U ORGANICAS TERAPEUTICAMENTE ACEPTABLES DE LOS COMPUESTOS DE FORMULA GENERAL (I) Y SUS POSIBLES HIDRATOS. LA INVENCION SE REFIERE TAMBIEN AL METODO DE PREPARACION DE LOS COMPUESTOS REIVINDICADOS Y A SU APLICACION COMO MEDICAMENTOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9509079A FR2737207B1 (fr) | 1995-07-26 | 1995-07-26 | Nouvelles n-heterocyclyl-1-aryloxyalcoyl-4-piperidinamines substituees, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2165514T3 true ES2165514T3 (es) | 2002-03-16 |
Family
ID=9481394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96927083T Expired - Lifetime ES2165514T3 (es) | 1995-07-26 | 1996-07-25 | Compuestos heterociclicos para el tratamiento de la isquemia miocardiaca. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6011032A (es) |
| EP (1) | EP0842174B1 (es) |
| JP (1) | JPH11509857A (es) |
| KR (1) | KR19990035986A (es) |
| CN (1) | CN1103338C (es) |
| AT (1) | ATE206423T1 (es) |
| AU (1) | AU707950B2 (es) |
| BR (1) | BR9609911A (es) |
| CA (1) | CA2228691A1 (es) |
| DE (1) | DE69615696T2 (es) |
| DK (1) | DK0842174T3 (es) |
| ES (1) | ES2165514T3 (es) |
| FR (1) | FR2737207B1 (es) |
| MX (1) | MX9800705A (es) |
| NZ (1) | NZ315347A (es) |
| PT (1) | PT842174E (es) |
| WO (1) | WO1997005134A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2788771B1 (fr) * | 1999-01-22 | 2001-04-13 | Pf Medicament | Nouvelles 1,2-alcoyl-1-[1-[aryl (alcoyl) oxyalcoyl] piperidin-4-yl]-3-aryl isothiourees substituees, leur preparation et leur application en therapeutique |
| FR2788775B1 (fr) * | 1999-01-22 | 2001-04-13 | Pf Medicament | Nouvelles n-alcoyl-n-[1-(omega-(arylalcoyloxy)alcoyl] piperidin-4-yl]-4h-3,1-benzo(thia/oxa)zines-2-amines substituees, leur preparation et leur application en therapeutique |
| WO2000066579A1 (fr) * | 1999-04-28 | 2000-11-09 | Banyu Pharmaceutical Co., Ltd. | Methodes de preparation de derives de piperidylmethylpyridine |
| FR3001151B1 (fr) | 2013-01-21 | 2016-04-08 | Pf Medicament | Association d'un bloqueur de courant sodique lent et d'un inhibiteur du courant if sinusal et les compositions pharmarceutiques la contenant |
| CN114349745B (zh) * | 2022-01-14 | 2023-12-08 | 黑龙江中医药大学 | 一种用于治疗心肌缺血的药物及其制备方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1260474A (en) * | 1984-12-03 | 1989-09-26 | Raymond A. Stokbroekx | Benzoxazol- and benzothiazolamine derivatives |
-
1995
- 1995-07-26 FR FR9509079A patent/FR2737207B1/fr not_active Expired - Fee Related
-
1996
- 1996-07-25 KR KR1019980700648A patent/KR19990035986A/ko not_active Ceased
- 1996-07-25 NZ NZ315347A patent/NZ315347A/xx unknown
- 1996-07-25 DK DK96927083T patent/DK0842174T3/da active
- 1996-07-25 EP EP96927083A patent/EP0842174B1/fr not_active Expired - Lifetime
- 1996-07-25 AU AU67031/96A patent/AU707950B2/en not_active Ceased
- 1996-07-25 WO PCT/FR1996/001176 patent/WO1997005134A1/fr not_active Application Discontinuation
- 1996-07-25 AT AT96927083T patent/ATE206423T1/de not_active IP Right Cessation
- 1996-07-25 JP JP9507283A patent/JPH11509857A/ja active Pending
- 1996-07-25 ES ES96927083T patent/ES2165514T3/es not_active Expired - Lifetime
- 1996-07-25 PT PT96927083T patent/PT842174E/pt unknown
- 1996-07-25 US US09/011,207 patent/US6011032A/en not_active Expired - Fee Related
- 1996-07-25 CN CN96196566A patent/CN1103338C/zh not_active Expired - Fee Related
- 1996-07-25 CA CA002228691A patent/CA2228691A1/fr not_active Abandoned
- 1996-07-25 DE DE69615696T patent/DE69615696T2/de not_active Expired - Fee Related
- 1996-07-25 BR BR9609911A patent/BR9609911A/pt not_active IP Right Cessation
-
1998
- 1998-01-23 MX MX9800705A patent/MX9800705A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| DE69615696D1 (de) | 2001-11-08 |
| CA2228691A1 (fr) | 1997-02-13 |
| MX9800705A (es) | 1998-10-31 |
| CN1103338C (zh) | 2003-03-19 |
| EP0842174A1 (fr) | 1998-05-20 |
| BR9609911A (pt) | 1999-03-02 |
| DK0842174T3 (da) | 2002-01-28 |
| EP0842174B1 (fr) | 2001-10-04 |
| FR2737207B1 (fr) | 1997-10-17 |
| DE69615696T2 (de) | 2002-07-11 |
| PT842174E (pt) | 2002-03-28 |
| ATE206423T1 (de) | 2001-10-15 |
| NZ315347A (en) | 2000-01-28 |
| JPH11509857A (ja) | 1999-08-31 |
| CN1193972A (zh) | 1998-09-23 |
| WO1997005134A1 (fr) | 1997-02-13 |
| AU6703196A (en) | 1997-02-26 |
| KR19990035986A (ko) | 1999-05-25 |
| US6011032A (en) | 2000-01-04 |
| FR2737207A1 (fr) | 1997-01-31 |
| AU707950B2 (en) | 1999-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69331414D1 (de) | Depsipeptide, herstellung und anwendung | |
| PT915866E (pt) | Processo aperfeicoado para a sintese de esteres protegidos do acido (s)-3,4-di-hidroxibutirico | |
| FI974447A0 (fi) | Semikarbatsonit, joilla on keskushermostoaktiivisuutta, ja niitä sisältävät farmaseuttiset valmisteet | |
| ATE205205T1 (de) | Durch hetero-aromatische ring substituierte phenyloxazolidinone als antimikrobielles mittel | |
| ES2139943T3 (es) | Nuevos inhibidores de la sintasa de prostaglandina. | |
| BR9911348A (pt) | Agentes para o combate de pragas vegetais | |
| PE20011067A1 (es) | Glutarimidas sustituidas, su preparacion, medicamentos que las contienen, y uso de las mismas para la fabricacion de medicamentos, especialmente inmunomoduladores, como asi tambien inhibidores de angiopatias y/o enfermedades hematologicas/oncologicas | |
| EP0720852A4 (en) | MEDICINE FOR NERVOUS DISEASES | |
| DE69530511D1 (de) | Enantioselective herstellung von pharmazeutisch aktiven sulfoxiden durch bioreduktion | |
| RS49792B (sr) | Piperidinilaminometil trifluorometil ciklična etarska jedinjenja kao antagonisti supstance | |
| BR9508608A (pt) | Composto formulação farmacêutica e processo para prevenir ou tratar arritmia | |
| DE69607650D1 (de) | 2,3,5-trimethyl-hydroxyanilid-derivative, ihre herstellung und ihre theraoeutische verwendung | |
| ID26622A (id) | Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide | |
| ES2165514T3 (es) | Compuestos heterociclicos para el tratamiento de la isquemia miocardiaca. | |
| BR1100207A (pt) | Processo para a preparação de derivados de hexa-hidroazepina | |
| PT100682A (pt) | Agentes anti-helminticos derivados de benzimidazole e processo para a sua preparacao | |
| UY26568A1 (es) | Nuevos derivados de amidas heterocíclicas | |
| DE60113808D1 (de) | Therapeutikum oder Prophylaktikum für Lebererkrankungen, enthaltend ein Diaminotrifluorethylpyridin-Derivat | |
| ES2128760T3 (es) | Nuevos oxidos de fosfanos, procedimiento para su preparacion asi como medicamentos que contienen estos compuestos. | |
| EA199800931A1 (ru) | Способ получения ингибиторов фосфодиэстеразы iv | |
| DK0675890T3 (da) | Kondenserede benzo(d)isoxazolderivater og anvendelse deraf som psykoaktive midler | |
| DE3671014D1 (de) | Cyclohexan-1,3-dionderivate, diese enthaltende zusammensetzungen, verfahren zu deren herstellung und deren verwendung als herbizide und pflanzenwachstumsregulatoren. | |
| ECSP003484A (es) | Derivados de 1-trifluorometil- 4 -hidroxi-7-piperidinil-aminome-tilcromano | |
| TH21054A (th) | อนุพันธ์ซัลโพแนมีดของแอโซโลน | |
| BR9915371A (pt) | Processos para a preparação de um composto de 1, 4-diaril-2-fluoro-1, 3-butadieno e de um composto de 1, 4-diaril-2-fluoro-2-buteno |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 842174 Country of ref document: ES |